BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

1.96
Delayed Data
As of Apr 03
 -0.035 / -1.76%
Today’s Change
1.38
Today|||52-Week Range
9.26
-43.33%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +232.48% increase from the last price of 1.96.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$4.3M
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1,133.34%
 
 
 
 
 
 
Growthannually 0.35%
 
 
 
 
 
 

Sales

Growthquarterly -89.20%
 
 
 
 
 
 
Growthannually -42.09%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.